Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Starting soon Not applicable

Delayed Morning Training, Sleep, and Change-of-Direction Performance in Badminton Athletes

NCT07873203 · tracked via the Priya Life Science China tracker
Phase
Not applicable
Started
2026-11-01
Last updated
2026-10-14

Condition(s) studied

Sleep DurationAthletic Performance

Investigational drug(s) / intervention(s)

Usual Morning Training ScheduleDelayed Morning Training Schedule

Usual Morning Training Schedule: Participants assigned to the usual morning-training group will begin each scheduled morning training session at 7:00 AM. The intervention will last for 3 consecutive weeks, with five morning-training sessions per week and 15 sessions in total. Each session will last approximately 90 minutes and will include standardized warm-up, badminton-specific technical training, footwork and change-of-direction exercises, multi-shuttle or tactical training, and cool-down. Training content, duration, workload, rest intervals, coaching arrangements, venue, diet, and recovery procedures will be matched to those of the delayed morning-training group.

Delayed Morning Training Schedule: Participants assigned to the delayed morning-training group will begin each scheduled morning training session at 9:00 AM, representing a 120-minute delay from the usual 7:00 AM schedule. The intervention will last for 3 consecutive weeks, with five morning-training sessions per week and 15 sessions in total. Each session will last approximately 90 minutes and will follow the same standardized training content and workload as the usual morning-training group. No mandatory roll call, early class, group activity, or other required task will be scheduled before the 9:00 AM training session.

Study summary

This randomized controlled trial will investigate whether delaying the start of morning training from 7:00 AM to 9:00 AM improves nocturnal sleep and change-of-direction performance in elite badminton athletes. A total of 38 athletes with an established morning-training routine will be randomly assigned in a 1:1 ratio to either a usual morning-training group starting at 7:00 AM or a delayed morning-training group starting at 9:00 AM. Both groups will follow the same training content, duration, intensity, coaching arrangements, and recovery procedures for three weeks.

Nocturnal sleep will be objectively monitored using wrist-worn activity monitors, with total sleep time as the primary outcome. Change-of-direction performance will be assessed using the modified 505 test. Additional outcomes will include sleep opportunity, sleep efficiency, sleep onset latency, nighttime awakenings, bedtime and wake time, nap duration, 24-hour total sleep, training load, and training adherence.

The study aims to determine whether a later morning-training schedule can provide athletes with greater sleep opportunity without compromising training quality or physical performance.

Eligibility

Sex
ALL
Min age
18 Years
Max age
35 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Elite badminton athletes receiving systematic professional badminton training and able to competently perform the modified 505 change-of-direction test. * A stable morning-training schedule during the previous 4 weeks. * Ability to maintain the same training phase, training location, and accommodation conditions throughout the study period. * Ability to complete baseline monitoring, the 3-week intervention, and pre- and post-intervention assessments. * Ability to understand the study procedures and willingness to provide written informed consent. Exclusion Criteria: * Injury or musculoskeletal condition that prevents safe completion of maximal-effort change-of-direction testing. * Unstable cardiovascular, neurological, or other health conditions. * Deemed unsuitable for maximal-effort training or testing by sports medicine personnel. * Planned participation in a major competition, off-site training camp, or trans-time-zone travel during the study period. * A previously diagnosed sleep disorder. * Inability to comply with activity-monitor wear, sleep-diary completion, or assigned training-time requirements.

Primary outcome measure(s)

  • Average Nocturnal Total Sleep Time During the Intervention Period — Throughout the 3-week intervention period, from Day 1 through Day 21
    Nocturnal total sleep time will be objectively measured using a wrist-worn activity monitor. Total sleep time is defined as the total number of minutes classified as sleep within the main nocturnal sleep period, excluding periods classified as wakefulness. The primary outcome will be calculated for each participant as the mean nocturnal total sleep time across valid target nights during the 3-week intervention period. Higher values indicate longer nocturnal sleep duration.

Trial sites (1)

FacilityCityRegionStatus
Capital University of Physical Education and Sports Beijing Beijing Municipality
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07873203 on ClinicalTrials.gov ↗ ← All trials in China